What is Scotiabank's Estimate for Savaria FY2026 Earnings?

Key Points

• Scotiabank lowered its FY2026 EPS estimate for Savaria to C$1.38 from C$1.39, still above the broader consensus estimate of C$1.20.
• Savaria reported quarterly EPS of C$0.35 on revenue of C$245.78 million, with a 13.41% return on equity and a 9.27% net margin.
• Analyst sentiment remains positive, with the stock carrying a consensus “Buy” rating and an average price target of C$34.33; however, insiders sold 81,747 shares worth approximately C$2.45 million over the past 90 days.

Savaria Co. (TSE:SIS - Free Report) - Investment analysts at Scotiabank cut their FY2026 earnings per share (EPS) estimates for shares of Savaria in a report issued on Wednesday, August 19th. Scotiabank analyst J. Goldman now expects that the company will post earnings of $1.38 per share for the year, down from their prior estimate of $1.39. The consensus estimate for Savaria's current full-year earnings is $1.20 per share.

Savaria (TSE:SIS - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported C$0.35 earnings per share (EPS) for the quarter. The business had revenue of C$245.78 million for the quarter. Savaria had a return on equity of 13.41% and a net margin of 9.27%.

SIS has been the topic of a number of other reports. TD lifted their price target on shares of Savaria from C$35.00 to C$37.00 and gave the company a "buy" rating in a report on Friday, August 7th. ATB Cormark Capital Markets boosted their price objective on shares of Savaria from C$35.00 to C$38.00 and gave the company an "outperform" rating in a research report on Friday, August 7th. TD Securities upgraded shares of Savaria to a "strong-buy" rating in a research note on Friday, July 24th. Finally, Desjardins raised their target price on shares of Savaria from C$36.00 to C$39.00 and gave the stock a "buy" rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating and eight have given a Buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of C$34.33.

Savaria Price Performance

SIS stock opened at C$28.66 on Monday. The firm has a market cap of C$2.07 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 42.72 and a beta of 1.04. Savaria has a 1-year low of C$20.10 and a 1-year high of C$31.95. The firm has a fifty day moving average price of C$29.81 and a two-hundred day moving average price of C$28.17. The company has a debt-to-equity ratio of 29.43, a current ratio of 1.72 and a quick ratio of 0.91.

Insider Buying and Selling

In other Savaria news, Director Marcel Bourassa sold 7,500 shares of the stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of C$29.53, for a total value of C$221,475.00. Following the sale, the director directly owned 225,431 shares of the company's stock, valued at C$6,656,977.43. This trade represents a 3.22% decrease in their ownership of the stock. Also, Director Peter Allen Drutz sold 9,736 shares of the firm's stock in a transaction on Saturday, June 6th. The shares were sold at an average price of C$29.00, for a total value of C$282,344.00. Following the completion of the sale, the director owned 95,251 shares in the company, valued at C$2,762,279. The trade was a 9.27% decrease in their ownership of the stock. Insiders have sold 81,747 shares of company stock valued at $2,448,032 in the last 90 days. Corporate insiders own 17.45% of the company's stock.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.